NYSE - Nasdaq Real Time Price USD

Agilent Technologies, Inc. (A)

Compare
137.47
+0.47
+(0.34%)
At close: January 10 at 4:00:02 PM EST
135.28
-2.19
(-1.59%)
After hours: January 10 at 7:59:41 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
10/31/2024
10/31/2023
10/31/2022
10/31/2021
Total Revenue
6,510,000.00
6,510,000.00
6,833,000.00
6,848,000.00
6,319,000.00
Cost of Revenue
2,975,000.00
2,975,000.00
3,368,000.00
3,126,000.00
2,912,000.00
Gross Profit
3,535,000.00
3,535,000.00
3,465,000.00
3,722,000.00
3,407,000.00
Operating Expense
2,047,000.00
2,047,000.00
2,115,000.00
2,104,000.00
2,060,000.00
Operating Income
1,488,000.00
1,488,000.00
1,350,000.00
1,618,000.00
1,347,000.00
Net Non Operating Interest Income Expense
-16,000.00
-16,000.00
-44,000.00
-75,000.00
-79,000.00
Other Income Expense
49,000.00
49,000.00
33,000.00
-39,000.00
92,000.00
Pretax Income
1,521,000.00
1,521,000.00
1,339,000.00
1,504,000.00
1,360,000.00
Tax Provision
232,000.00
232,000.00
99,000.00
250,000.00
150,000.00
Net Income Common Stockholders
1,289,000.00
1,289,000.00
1,240,000.00
1,254,000.00
1,210,000.00
Diluted NI Available to Com Stockholders
1,289,000.00
1,289,000.00
1,240,000.00
1,254,000.00
1,210,000.00
Basic EPS
4.44
--
4.22
4.19
3.98
Diluted EPS
4.43
--
4.19
4.18
3.94
Basic Average Shares
290,000.00
--
294,000.00
299,000.00
304,000.00
Diluted Average Shares
291,000.00
--
296,000.00
300,000.00
307,000.00
Total Operating Income as Reported
1,488,000.00
1,488,000.00
1,350,000.00
1,618,000.00
1,347,000.00
Total Expenses
5,022,000.00
5,022,000.00
5,483,000.00
5,230,000.00
4,972,000.00
Net Income from Continuing & Discontinued Operation
1,289,000.00
1,289,000.00
1,240,000.00
1,254,000.00
1,210,000.00
Normalized Income
1,289,000.00
1,289,000.00
1,240,000.00
1,254,000.00
1,210,000.00
Interest Income
80,000.00
80,000.00
51,000.00
9,000.00
2,000.00
Interest Expense
96,000.00
96,000.00
95,000.00
84,000.00
81,000.00
Net Interest Income
-16,000.00
-16,000.00
-44,000.00
-75,000.00
-79,000.00
EBIT
1,617,000.00
1,617,000.00
1,434,000.00
1,588,000.00
1,441,000.00
EBITDA
1,874,000.00
1,874,000.00
1,705,000.00
1,905,000.00
1,762,000.00
Reconciled Cost of Revenue
2,975,000.00
2,975,000.00
3,368,000.00
3,126,000.00
2,912,000.00
Reconciled Depreciation
257,000.00
257,000.00
271,000.00
317,000.00
321,000.00
Net Income from Continuing Operation Net Minority Interest
1,289,000.00
1,289,000.00
1,240,000.00
1,254,000.00
1,210,000.00
Normalized EBITDA
1,874,000.00
1,874,000.00
1,705,000.00
1,905,000.00
1,762,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
10/31/2021 - 11/18/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WAT Waters Corporation
380.35
+1.64%
 
TMO Thermo Fisher Scientific Inc.
542.31
-0.48%
 
DHR Danaher Corporation
235.07
-1.27%
 
MTD Mettler-Toledo International Inc.
1,210.99
-2.85%
 
IDXX IDEXX Laboratories, Inc.
418.05
-3.31%
 
IQV IQVIA Holdings Inc.
203.27
-0.51%
 
ILMN Illumina, Inc.
136.69
-2.14%
 
LH Labcorp Holdings Inc.
232.00
-0.99%
 
CRL Charles River Laboratories International, Inc.
186.12
-0.95%
 
DGX Quest Diagnostics Incorporated
151.79
-1.45%